Vulnerability · Published Jun 4, 2020 · Assigned by mitre
CVE-2020-13791
Medium 5.5
In plain English
A medium-severity security flaw in the qemu package (Alpine). There are no confirmed reports of exploitation so far. The chance it is exploited in the next 30 days is estimated at 0.4% (higher than 34% of all known vulnerabilities). Fixed versions are available - upgrade the affected package.
Severity (CVSS NVD)5.5Medium
Exploit odds (30 days)0.4%top 65.8% of all CVEs
Exploited in the wildNo reportsnot in CISA KEV
Attack toolingNoneno public tooling known
Official description
hw/pci/pci.c in QEMU 4.2.0 allows guest OS users to trigger an out-of-bounds access by providing an address near the end of the PCI configuration space.
Affected packages & fixed versions
| Ecosystem | Package | Fixed in | Advisory |
|---|---|---|---|
| Alpine:v3.20 | qemu | 5.0.0-r0 | ALPINE-CVE-2020-13791 |
| Alpine:v3.21 | qemu | 5.0.0-r0 | ALPINE-CVE-2020-13791 |
| Alpine:v3.22 | qemu | 5.0.0-r0 | ALPINE-CVE-2020-13791 |
| Alpine:v3.23 | qemu | 5.0.0-r0 | ALPINE-CVE-2020-13791 |
| Alpine:v3.24 | qemu | 5.0.0-r0 | ALPINE-CVE-2020-13791 |
| Debian:12 | qemu | 1:5.0-6 | DEBIAN-CVE-2020-13791 |
| Debian:13 | qemu | 1:5.0-6 | DEBIAN-CVE-2020-13791 |
| Debian:14 | qemu | 1:5.0-6 | DEBIAN-CVE-2020-13791 |
| Ubuntu:22.04:LTS | qemu | no fix listed | UBUNTU-CVE-2020-13791 |
| Ubuntu:24.04:LTS | qemu | no fix listed | UBUNTU-CVE-2020-13791 |
| Ubuntu:25.10 | qemu | no fix listed | UBUNTU-CVE-2020-13791 |
| Ubuntu:26.04:LTS | qemu | no fix listed | UBUNTU-CVE-2020-13791 |
| Ubuntu:26.10 | qemu | no fix listed | UBUNTU-CVE-2020-13791 |
| Ubuntu:26.04:LTS | qemu-hwe | no fix listed | UBUNTU-CVE-2020-13791 |
| Ubuntu:26.10 | qemu-hwe | no fix listed | UBUNTU-CVE-2020-13791 |
Affected products (as reported)
References
- https://lists.gnu.org/archive/html/qemu-devel/2020-06/msg00706.html x_refsource_MISC
- https://www.openwall.com/lists/oss-security/2020/06/04/1 x_refsource_CONFIRM
- https://security.netapp.com/advisory/ntap-20200717-0001/ x_refsource_CONFIRM
- GLSA-202011-09 vendor-advisory, x_refsource_GENTOO